Core Viewpoint - The market anticipates Appian (APPN) will report a year-over-year increase in earnings driven by higher revenues when it releases its quarterly results for the period ending March 2025 [1][2] Earnings Expectations - Appian is expected to report quarterly earnings of $0.03 per share, reflecting a year-over-year increase of +112.5% [3] - Revenue projections stand at $162.84 million, which is an increase of 8.7% compared to the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has been revised down by 6.82% over the last 30 days, indicating a reassessment by analysts regarding the company's earnings outlook [4] - The Most Accurate Estimate for Appian is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -25%, suggesting a bearish sentiment among analysts [10][11] Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict the likelihood of actual earnings deviating from consensus estimates, with positive readings being more reliable [7][8] - Appian currently holds a Zacks Rank of 3, which complicates the prediction of an earnings beat [11] Historical Performance - In the last reported quarter, Appian was expected to incur a loss of $0.01 per share but instead reported break-even earnings, resulting in a surprise of +100% [12] - Over the past four quarters, Appian has exceeded consensus EPS estimates three times [13] Conclusion - While Appian does not appear to be a strong candidate for an earnings beat, investors should consider other factors when making investment decisions ahead of the earnings release [16]

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Affirm Holdings due to higher revenues, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Affirm Holdings is expected to report a quarterly loss of $0.08 per share, reflecting an 81.4% improvement year-over-year, with revenues projected at $783.11 million, a 35.9% increase from the previous year [3]. - The earnings report is scheduled for May 8, 2025, and could lead to stock price increases if results exceed expectations [2]. Estimate Revisions - The consensus EPS estimate has been revised 4.88% higher in the last 30 days, indicating a positive reassessment by analysts [4]. - The Zacks Earnings ESP model suggests that recent estimate revisions may provide insights into business conditions leading up to the earnings release [5][6]. Earnings Surprise Potential - Affirm Holdings has a positive Earnings ESP of +63.27%, indicating a strong likelihood of beating the consensus EPS estimate, supported by a Zacks Rank of 1 [11]. - The company has a history of exceeding consensus EPS estimates, having done so in the last four quarters, including a significant surprise of +215% in the last reported quarter [12][13]. Conclusion - Affirm Holdings is positioned as a compelling candidate for an earnings beat, but investors should consider additional factors beyond earnings results when making investment decisions [16].

Core Viewpoint - The market anticipates a year-over-year decline in earnings for Altice USA, Inc. (ATUS) due to lower revenues, with a consensus estimate of a quarterly loss of $0.09 per share and revenues of $2.16 billion, reflecting a 3.9% decrease from the previous year [1][3]. Earnings Expectations - The upcoming earnings report is expected to be released on May 8, and the stock may rise if the actual results exceed expectations, while a miss could lead to a decline [2]. - The consensus EPS estimate has been revised down by 7.14% over the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that the Most Accurate Estimate for Altice USA is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +11.11% [10][11]. - However, the stock holds a Zacks Rank of 5, which complicates the prediction of an earnings beat [11]. Historical Performance - In the last reported quarter, Altice USA was expected to post earnings of $0.03 per share but instead reported a loss of $0.12, resulting in a surprise of -500% [12]. - The company has not beaten consensus EPS estimates in any of the last four quarters [13]. Conclusion - While Altice USA does not appear to be a strong candidate for an earnings beat, investors should consider other factors when making decisions regarding the stock ahead of the earnings release [16].

Core Viewpoint - The market anticipates a year-over-year decline in Allbirds, Inc. (BIRD) earnings due to lower revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - Allbirds is expected to report a quarterly loss of $3.85 per share, reflecting a -6.9% change year-over-year [3]. - Revenue is projected to be $30.87 million, down 21.5% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 1.67% lower in the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate is lower than the Zacks Consensus Estimate, leading to an Earnings ESP of -1.04%, suggesting a bearish outlook [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict earnings deviation, but its predictive power is significant mainly for positive readings [7][8]. - Stocks with a positive Earnings ESP and a Zacks Rank of 1, 2, or 3 have historically shown a nearly 70% chance of a positive surprise [8]. Historical Performance - In the last reported quarter, Allbirds was expected to post a loss of $3.52 per share but delivered a loss of $3.23, resulting in a surprise of +8.24% [12]. - Over the past four quarters, Allbirds has beaten consensus EPS estimates four times [13]. Conclusion - Allbirds does not appear to be a compelling earnings-beat candidate, and investors should consider other factors when making decisions regarding the stock ahead of the earnings release [16].

The market expects Dave Inc. (DAVE) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on ...

The market expects DraftKings (DKNG) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released o ...

The market expects HubSpot (HUBS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on M ...

Core Viewpoint - ImmunityBio (IBRX) is anticipated to report a year-over-year increase in earnings driven by higher revenues, with a consensus outlook suggesting a quarterly loss of $0.12 per share, reflecting a 40% improvement from the previous year, and revenues expected to reach $15.69 million, a staggering increase of 39,125% from the same quarter last year [1][3]. Earnings Expectations - The stock price may rise if the actual earnings exceed expectations in the upcoming report, while a miss could lead to a decline [2]. - The consensus EPS estimate has been revised down by 1.45% over the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for ImmunityBio is lower than the consensus estimate, resulting in an Earnings ESP of -2.85%, suggesting a bearish outlook [10][11]. - A positive Earnings ESP is generally a strong predictor of an earnings beat, especially when combined with a favorable Zacks Rank [8]. Historical Performance - In the last reported quarter, ImmunityBio was expected to post a loss of $0.26 per share but actually reported a loss of $0.15, resulting in a positive surprise of 42.31% [12]. - Over the past four quarters, the company has beaten consensus EPS estimates twice [13]. Comparative Industry Analysis - Pacira (PCRX), another player in the biomedical and genetics industry, is expected to report earnings of $0.57 per share, reflecting an 8.1% decline year-over-year, with revenues projected at $174.96 million, a 4.7% increase [17]. - Pacira's consensus EPS estimate has remained unchanged over the last 30 days, but it has an Earnings ESP of 34.51%, indicating a strong likelihood of beating the consensus estimate [18].

Wall Street expects a year-over-year increase in earnings on lower revenues when Golden Entertainment (GDEN) reports results for the quarter ended March 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on May 8 ...

Company Overview - Inter & Co. Inc. (INTR) is expected to report a year-over-year increase in earnings, with a projected EPS of $0.12, reflecting a change of +33.3% [3] - Revenues are anticipated to reach $327.02 million, which is a 15.6% increase from the same quarter last year [3] Earnings Expectations - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4] - The Most Accurate Estimate aligns with the Zacks Consensus Estimate, resulting in an Earnings ESP of 0%, suggesting no recent changes in analyst views [10] Earnings Surprise Prediction - A positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [8] - Inter & Co. Inc. currently holds a Zacks Rank of 2, making it challenging to predict an earnings beat conclusively [11] Historical Performance - In the last reported quarter, Inter & Co. Inc. exceeded the consensus EPS estimate of $0.10 by delivering $0.11, resulting in a surprise of +10% [12] - Over the past four quarters, the company has beaten consensus EPS estimates three times [13] Industry Context - In the Zacks Financial - Miscellaneous Services industry, HA Sustainable Infrastructure Capital (HASI) is expected to post earnings of $0.64 per share, indicating a year-over-year decline of -5.9% [17] - HASI's revenue is projected to be $33 million, down 21.3% from the previous year [17] - The consensus EPS estimate for HASI has been revised 0.8% higher in the last 30 days, but a lower Most Accurate Estimate results in an Earnings ESP of -3.91% [18]